Dr Gonzalo Tejeda

  • Research Associate (Molecular Biosciences)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2013 | 2011 | 2010 | 2009
Number of items: 19.

2024

Montezano, A. C. et al. (2024) Ang-(1-7) and ET-1 interplay through Mas and ETB receptor interaction defines a novel vasoprotective mechanism. Hypertension, (doi: 10.1161/HYPERTENSIONAHA.124.22693) (PMID:39633565) (Early Online Publication)

2023

Wright, T. A., Gemmell, A. O., Tejeda, G. S. , Blair, C. M. and Baillie, G. S. (2023) Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target. International Journal of Biochemistry and Cell Biology, 162, 106453. (doi: 10.1016/j.biocel.2023.106453) (PMID:37499270)

2022

Dwomoh, L. , Tejeda, G. S. and Tobin, A. B. (2022) Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease. Neuronal Signaling, 6(1), NS20210004. (doi: 10.1042/NS20210004) (PMID:35571495) (PMCID:PMC9069568)

Tibbo, A. J. et al. (2022) Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins. Journal of Molecular and Cellular Cardiology, 165, pp. 86-102. (doi: 10.1016/j.yjmcc.2022.01.001) (PMID:34999055) (PMCID:PMC8986152)

2021

Scarpa, M. et al. (2021) Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. Proceedings of the National Academy of Sciences of the United States of America, 118(50), e2107389118. (doi: 10.1073/pnas.2107389118) (PMID:34893539) (PMCID:PMC8685681)

Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)

2020

Tejeda, G. S. , Whiteley, E. L., Deeb, T. Z., Bürli, R. W., Moss, S. J., Sheridan, E., Brandon, N. J. and Baillie, G. S. (2020) Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme. Proceedings of the National Academy of Sciences of the United States of America, 117(1), pp. 677-688. (doi: 10.1073/pnas.1916398117) (PMID:31871190) (PMCID:PMC6955301)

2019

Baillie, G. S. , Tejeda, G. S. and Kelly, M. P. (2019) Therapeutic targeting of 3’,5’-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nature Reviews Drug Discovery, 18, pp. 770-796. (doi: 10.1038/s41573-019-0033-4) (PMID:31388135)

Tibbo, A. J., Tejeda, G. S. and Baillie, G. S. (2019) Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches. Biochemical Society Transactions, 47(5), pp. 1557-1565. (doi: 10.1042/BST20190763) (PMID:31642904) (PMCID:PMC6824677)

Whiteley, E. L., Tejeda, G. S. , Baillie, G. S. and Brandon, N. J. (2019) PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders. Cellular Signalling, 60, pp. 31-38. (doi: 10.1016/j.cellsig.2019.04.001) (PMID:30951862)

2017

Tejeda, G. and Díaz-Guerra, M. (2017) Integral characterization of defective BDNF/TrkB signalling in neurological and psychiatric disorders leads the way to new therapies. International Journal of Molecular Sciences, 18(2), 268. (doi: 10.3390/ijms18020268) (PMID:28134845) (PMCID:PMC5343804)

2016

Tejeda, G. S. , Ayuso-Dolado, S., Arbeteta, R., Esteban-Ortega, G. M., Vidaurre, O. G. and Díaz-Guerra, M. (2016) Brain ischaemia induces shedding of a BDNF-scavenger ectodomain from TrkB receptors by excitotoxicity activation of metalloproteinases and γ-secretases. Journal of Pathology, 238(5), pp. 627-640. (doi: 10.1002/path.4684) (PMID:26712630)

2015

Gamir-Morralla, A., López-Menéndez, C., Ayuso-Dolado, S., Tejeda, G.S. , Montaner, J., Rosell, A., Iglesias, T. and Díaz-Guerra, M. (2015) Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity. Cell Death and Disease, 6(10), e1939. (doi: 10.1038/cddis.2015.307) (PMID:26492372) (PMCID:PMC4632323)

2013

Nishijima, T., Llorens-Martín, M., Tejeda, G. S. , Inoue, K., Yamamura, Y., Soya, H., Trejo, J. L. and Torres-Alemán, I. (2013) Cessation of voluntary wheel running increases anxiety-like behavior and impairs adult hippocampal neurogenesis in mice. Behavioural Brain Research, 245, pp. 34-41. (doi: 10.1016/j.bbr.2013.02.009) (PMID:23428744)

2011

Llorens-Martín, M., Tejeda, G. S. and Trejo, J. L. (2011) Antidepressant and proneurogenic influence of environmental enrichment in mice: Protective effects vs recovery. Neuropsychopharmacology, 36(12), pp. 2460-2468. (doi: 10.1038/npp.2011.134) (PMID:21796111) (PMCID:PMC3194073)

2010

Llorens-Martín, M.V., Rueda, N., Tejeda, G.S. , Flórez, J., Trejo, J.L. and Martínez-Cué, C. (2010) Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. Neuroscience, 171(4), pp. 1228-1240. (doi: 10.1016/j.neuroscience.2010.09.043) (PMID:20875841)

Tsien, J. Z., Llorens-Martín, M., Tejeda, G. S. and Trejo, J. L. (2010) Differential regulation of the variations induced by environmental richness in adult neurogenesis as a function of time: A dual birthdating analysis. PLoS ONE, 5(8), e12188. (doi: 10.1371/journal.pone.0012188) (PMID:20808440) (PMCID:PMC2922333)

2009

Bodega, G., Ciordia, S., Suárez, I., López-Fernández, L. A., Vacas, E., Tejeda, G. S. , Albert, M. A., Juárez, S., Albar, J. P. and Fernández, B. (2009) Astrocytes express Mxi2, a splice isoform of p38MAPK. Journal of Molecular Histology, 40(5-6), pp. 325-329. (doi: 10.1007/s10735-009-9248-8) (PMID:20043236)

This list was generated on Sun Dec 22 05:56:16 2024 GMT.
Jump to: Articles
Number of items: 19.

Articles

Montezano, A. C. et al. (2024) Ang-(1-7) and ET-1 interplay through Mas and ETB receptor interaction defines a novel vasoprotective mechanism. Hypertension, (doi: 10.1161/HYPERTENSIONAHA.124.22693) (PMID:39633565) (Early Online Publication)

Wright, T. A., Gemmell, A. O., Tejeda, G. S. , Blair, C. M. and Baillie, G. S. (2023) Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target. International Journal of Biochemistry and Cell Biology, 162, 106453. (doi: 10.1016/j.biocel.2023.106453) (PMID:37499270)

Dwomoh, L. , Tejeda, G. S. and Tobin, A. B. (2022) Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease. Neuronal Signaling, 6(1), NS20210004. (doi: 10.1042/NS20210004) (PMID:35571495) (PMCID:PMC9069568)

Tibbo, A. J. et al. (2022) Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins. Journal of Molecular and Cellular Cardiology, 165, pp. 86-102. (doi: 10.1016/j.yjmcc.2022.01.001) (PMID:34999055) (PMCID:PMC8986152)

Scarpa, M. et al. (2021) Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. Proceedings of the National Academy of Sciences of the United States of America, 118(50), e2107389118. (doi: 10.1073/pnas.2107389118) (PMID:34893539) (PMCID:PMC8685681)

Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)

Tejeda, G. S. , Whiteley, E. L., Deeb, T. Z., Bürli, R. W., Moss, S. J., Sheridan, E., Brandon, N. J. and Baillie, G. S. (2020) Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme. Proceedings of the National Academy of Sciences of the United States of America, 117(1), pp. 677-688. (doi: 10.1073/pnas.1916398117) (PMID:31871190) (PMCID:PMC6955301)

Baillie, G. S. , Tejeda, G. S. and Kelly, M. P. (2019) Therapeutic targeting of 3’,5’-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nature Reviews Drug Discovery, 18, pp. 770-796. (doi: 10.1038/s41573-019-0033-4) (PMID:31388135)

Tibbo, A. J., Tejeda, G. S. and Baillie, G. S. (2019) Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches. Biochemical Society Transactions, 47(5), pp. 1557-1565. (doi: 10.1042/BST20190763) (PMID:31642904) (PMCID:PMC6824677)

Whiteley, E. L., Tejeda, G. S. , Baillie, G. S. and Brandon, N. J. (2019) PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders. Cellular Signalling, 60, pp. 31-38. (doi: 10.1016/j.cellsig.2019.04.001) (PMID:30951862)

Tejeda, G. and Díaz-Guerra, M. (2017) Integral characterization of defective BDNF/TrkB signalling in neurological and psychiatric disorders leads the way to new therapies. International Journal of Molecular Sciences, 18(2), 268. (doi: 10.3390/ijms18020268) (PMID:28134845) (PMCID:PMC5343804)

Tejeda, G. S. , Ayuso-Dolado, S., Arbeteta, R., Esteban-Ortega, G. M., Vidaurre, O. G. and Díaz-Guerra, M. (2016) Brain ischaemia induces shedding of a BDNF-scavenger ectodomain from TrkB receptors by excitotoxicity activation of metalloproteinases and γ-secretases. Journal of Pathology, 238(5), pp. 627-640. (doi: 10.1002/path.4684) (PMID:26712630)

Gamir-Morralla, A., López-Menéndez, C., Ayuso-Dolado, S., Tejeda, G.S. , Montaner, J., Rosell, A., Iglesias, T. and Díaz-Guerra, M. (2015) Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity. Cell Death and Disease, 6(10), e1939. (doi: 10.1038/cddis.2015.307) (PMID:26492372) (PMCID:PMC4632323)

Nishijima, T., Llorens-Martín, M., Tejeda, G. S. , Inoue, K., Yamamura, Y., Soya, H., Trejo, J. L. and Torres-Alemán, I. (2013) Cessation of voluntary wheel running increases anxiety-like behavior and impairs adult hippocampal neurogenesis in mice. Behavioural Brain Research, 245, pp. 34-41. (doi: 10.1016/j.bbr.2013.02.009) (PMID:23428744)

Llorens-Martín, M., Tejeda, G. S. and Trejo, J. L. (2011) Antidepressant and proneurogenic influence of environmental enrichment in mice: Protective effects vs recovery. Neuropsychopharmacology, 36(12), pp. 2460-2468. (doi: 10.1038/npp.2011.134) (PMID:21796111) (PMCID:PMC3194073)

Llorens-Martín, M.V., Rueda, N., Tejeda, G.S. , Flórez, J., Trejo, J.L. and Martínez-Cué, C. (2010) Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. Neuroscience, 171(4), pp. 1228-1240. (doi: 10.1016/j.neuroscience.2010.09.043) (PMID:20875841)

Tsien, J. Z., Llorens-Martín, M., Tejeda, G. S. and Trejo, J. L. (2010) Differential regulation of the variations induced by environmental richness in adult neurogenesis as a function of time: A dual birthdating analysis. PLoS ONE, 5(8), e12188. (doi: 10.1371/journal.pone.0012188) (PMID:20808440) (PMCID:PMC2922333)

Bodega, G., Ciordia, S., Suárez, I., López-Fernández, L. A., Vacas, E., Tejeda, G. S. , Albert, M. A., Juárez, S., Albar, J. P. and Fernández, B. (2009) Astrocytes express Mxi2, a splice isoform of p38MAPK. Journal of Molecular Histology, 40(5-6), pp. 325-329. (doi: 10.1007/s10735-009-9248-8) (PMID:20043236)

This list was generated on Sun Dec 22 05:56:16 2024 GMT.

Research datasets

Jump to: 2021
Number of items: 1.

2021

Scarpa, M., Molloy, C. , Jenkins, L. , Strellis, B., Budgett, R., Hesse, S., Dwomoh, L. , Marsango, S., Tejeda, G. , Rossi, M., Ahmed, Z., Milligan, G. , Hudson, B. , Tobin, A. , Bradley, S. and Heptares, S. (2021) Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. [Data Collection]

This list was generated on Sat Dec 21 23:40:47 2024 GMT.